Takanobu Utsumi

Takanobu Utsumi

Auto-generated profile, based on publicly available information

Takanobu Utsumi

Department of Urology Toho University Sakura Medical Center Chiba Japan

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2023 in International Journal of Urology
Verified
Journal Article
Closed access
TUTakanobu Utsumi
Takanobu Utsumi
SIShota Iijima
Shota Iijima
YSYuka Sugizaki
Yuka Sugizaki
TMTakamichi Mori
Takamichi Mori
TSTakatoshi Somoto
Takatoshi Somoto
HSHiroyoshi Suzuki
Hiroyoshi Suzuki

1 July 2016 in Asian Journal of Surgery
Verified
Journal Article
Open access
TNTAKESHI NAMEKAWA
TAKESHI NAMEKAWA
TUTakanobu Utsumi
Takanobu Utsumi
TITakashi Imamoto
Takashi Imamoto
KKKoji Kawamura
Koji Kawamura
TOTakashi Oide
Takashi Oide
TITomohiko Ichikawa
Tomohiko Ichikawa
Adrenal tumors with more than one cellular component are uncommon. Furthermore, an adrenal tumor composed of a pheochromocytoma and a malignant peripheral nerve sheath tumor is extremely rare. A composite pheochromocytoma with malignant peripheral nerve sheath tumor in a 42-year-old man is reported here. After adequate preoperative control, left adrenalectomy was performed simultaneously with resection of the ipsilateral kidney for spontaneous rupture of the left adrenal tumor. Pathological findings demonstrated pheochromocytoma and malignant peripheral nerve sheath tumor in a ruptured adrenal tumor. To date, there have been only four reported cases of composite pheochromocytoma with malignant peripheral nerve sheath tumor, so the present case is only the fifth case in the world. Despite the very poor prognosis of patients with pheochromocytoma and malignant peripheral nerve sheath tumors reported in the literature, the patient remains well without evidence of recurrence or new metastatic lesions at 36 months postoperatively.

1 January 2011 in Prostate Cancer
Verified
Journal Article
Open access
PDF file
TITakashi Imamoto
Takashi Imamoto
TUTakanobu Utsumi
Takanobu Utsumi
MTMakoto Takano
Makoto Takano
AKAtsushi Komaru
Atsushi Komaru
SFSatoshi Fukasawa
Satoshi Fukasawa
TITomohiko Ichikawa
Tomohiko Ichikawa
Objective. The aim of this study is to develop a prognostic model capable of predicting the probability of significant upgrading among Japanese patients.Methods. The study cohort comprised 508 men treated with RP, with available prostate-specific antigen levels, biopsy, and RP Gleason sum values. Clinical and pathological data from 258 patients were obtained from another Japanese institution for validation.Results. Significant Gleason sum upgrading was recorded in 92 patients (18.1%) at RP. The accuracy of the nomogram predicting the probability of significant Gleason sum upgrading between biopsy and RP specimens was 88.9%. Overall AUC was 0.872 when applied to the validation data set. Nomogram predictions of significant upgrading were within 7.5% of an ideal nomogram.Conclusions. Nearly one-fifth of Japanese patients with prostate cancer will be significantly upgraded. Our nomogram seems to provide considerably accurate predictions regardless of minor variations in pathological assessment when applied to Japanese patient populations.